Latest / Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology
Exenatide in Parkinson’s disease phase 3 trial
Exenatide once a week versus placebo as a potential diseasemodifying treatment for people with Parkinson’s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial #Neurology #Parkinson
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.